Stifel Maintains Buy on IDEAYA Biosciences, Raises Price Target to $63
Portfolio Pulse from Benzinga Newsdesk
Stifel analyst Benjamin Burnett maintains a Buy rating on IDEAYA Biosciences (NASDAQ:IDYA) and raises the price target from $55 to $63.
June 04, 2024 | 12:14 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Stifel analyst Benjamin Burnett maintains a Buy rating on IDEAYA Biosciences and raises the price target from $55 to $63, indicating strong confidence in the company's future performance.
The raised price target from $55 to $63 by a reputable analyst suggests increased confidence in IDEAYA Biosciences' future performance, likely leading to positive short-term price movement.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100